SCHEMBL23584566

SCHEMBL23584566

C=C[C@H]1[C@@H](COC(C)(C)O)[C@H](c2ccc3c(N)ncnn23)O[C@@H]1CN1CCC(F)(F)C[C@H]1CN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19344282 0.82 POLRMT (0.30) —
SCHEMBL19344160 0.82 POLRMT (0.35) —
SCHEMBL19344169 0.82 POLRMT (0.35) —
SCHEMBL19344281 0.78 POLRMT (0.31) —
SCHEMBL23584756 0.76 CSNK2A2 (0.30) —
SCHEMBL23584801 0.75 POLRMT (0.32) —
SCHEMBL22435033 0.74 — —
SCHEMBL19344162 0.74 POLRMT (0.35) —
SCHEMBL19344087 0.73 — —
SCHEMBL23584569 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback